15045ETCTN-10204-NCT03816345OpenA Phase Ib Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO).10204NCT03816345NationalAdultTreatmentIMultipleGibney, GeoffreyGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterPhase I; Phase I/SarcomaOncology GroupLombardi Comprehensive Cancer Center (LCCC)2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>